| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRK | Common Stock | Options Exercise | $0 | +19.3 K | +20.48% | $0.00 | 114 K | May 10, 2021 | Direct | |
| transaction | MRK | Common Stock | Sale | -$1.51 M | -19.3 K | -17% | $78.32 | 94.3 K | May 10, 2021 | Direct | F1, F2 |
| holding | MRK | Common Stock - 401(k) Plan | 1.75 K | May 10, 2021 | By 401(k) | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRK | Stock Option (Right to Buy) | Options Exercise | $0 | -19.3 K | -50% | $0.00 | 19.3 K | May 10, 2021 | Common Stock | 19.3 K | $44.98 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.27 to $78.42, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. |
| F2 | Holdings include shares acquired in dividend reinvestment transactions. |
| F3 | Includes shares acquired and dividends earned through April 7, 2021 in the Merck U.S. Savings Plan, a 401(k) plan. |
| F4 | The option became exercisable in equal installments on 5/6/2014, 5/6/2015 and 5/6/2016. |